Immediate Impact
1 from Science/Nature 22 standout
Citing Papers
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
2022 Standout
COVID-19 and the efficiency of health systems in Europe
2022 Standout
Works of Michael P. Chen being referenced
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
2016
A national study of socioeconomic status and tuberculosis rates by country of birth, United States, 1996–2005
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael P. Chen | 158 | 204 | 33 | 76 | 10 | 254 | |
| David Mametja | 157 | 204 | 19 | 60 | 9 | 248 | |
| E Jane Carter | 152 | 200 | 50 | 46 | 10 | 257 | |
| Deanna Tollefson | 170 | 245 | 30 | 110 | 11 | 320 | |
| Fentabil Getnet | 153 | 235 | 26 | 61 | 21 | 315 | |
| Dalene von Delft | 103 | 159 | 25 | 37 | 7 | 200 | |
| Annik Rouillon | 194 | 282 | 12 | 115 | 10 | 331 | |
| Emily J. Hecker | 209 | 205 | 33 | 89 | 15 | 326 | |
| D. Gelb | 202 | 96 | 42 | 44 | 11 | 322 | |
| Alberto Roggi | 158 | 210 | 14 | 60 | 15 | 297 | |
| Simon P. Johnstone-Robertson | 162 | 189 | 25 | 43 | 8 | 301 |
All Works
Loading papers...